Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
57 /100
COMPONENT-LIMITED
Score updated Oct 28, 2026

COAG — Hemab Therapeutics Holdings, Inc. Dilution Risk Tracker

Track COAG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COAG — Get alerts when the score changes →

As of October 28, 2026, Hemab Therapeutics Holdings, Inc. (COAG) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Hemab Therapeutics Holdings, Inc. has a market capitalization of $1.79B, 46.71M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for COAG.
🔔 Track COAG — Get forecast alerts →

Market Data

Market Cap$1.79B
Shares Outstanding46.71M
FloatN/A
Cash$457.46M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore57/100DilutionWatch score record
Shares Outstanding46.71MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$1.79BMarket data cache
Cash Runway62.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

COAG SEC Filing Activity — Last 12 Months

Shares outstanding reported by COAG on the cover page of its latest 10-K/10-Q: 46.71M as of July 31, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for COAG in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)1Aug 11, 2026
10-Qquarterly report1May 21, 2026
SC 13Gpassive >5% holder filing6Aug 14, 2026
4insider transaction2Sep 25, 2026

Institutional Holdings

59.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track COAG for full holder detail →

Short Interest

Short Interest3.16M
Days to Cover7.8
% of FloatN/A
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual COAG Dilution Snapshot

Hemab Therapeutics Holdings, Inc. (COAG) has a DilutionScore of 57/100, rated High dilution risk. Score date: October 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

COAG's DilutionScore is currently 57/100 (High risk), with 1 score change tracked over 89 days. The score deteriorated from 65/100 (High risk).

Period Score Risk Level Duration
Oct 14 – Oct 28, 202657/100HIGH15 days
Jul 31 – Oct 13, 202665/100HIGH74 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

COAG shares outstanding have increased 10.0% from 42.44M (May 2026) to 46.71M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202646.71M456.1K▼ 6.02%
May 16, 202646.71M485.3K▼ 10.39%
May 11, 202646.71M541.6K▼ 12.46%
May 06, 202646.71M618.7K▲ 18.04%
May 04, 202642.44M524.1K▲ 2099.99%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track COAG Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment COAG files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking COAG — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,567+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note